Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 59Carcinoma, Hepatocellular 46Colorectal Neoplasms 33Stomach Neoplasms 31Esophageal Squamous Cell Carcinoma 27Squamous Cell Carcinoma of Head and Neck 20Esophageal Neoplasms 14Small Cell Lung Carcinoma 13Neoplasm Metastasis 13Lung Neoplasms 13Rectal Neoplasms 12Head and Neck Neoplasms 12Advanced Solid Tumor 12Triple Negative Breast Neoplasms 11Cholangiocarcinoma 11Nasopharyngeal Carcinoma 10Melanoma 10Uterine Cervical Neoplasms 9Recurrence 9Neoplasms 9Colonic Neoplasms 9Pancreatic Neoplasms 7Urinary Bladder Neoplasms 6Solid Tumor 6Carcinoma, Transitional Cell 6Breast Neoplasms 6Sarcoma 5Lymphoma, Extranodal NK-T-Cell 5Lymphoma 5Hodgkin Disease 5

Interventions

Tomography, X-Ray Computed 3Positron Emission Tomography Computed Tomography 2Oxygen 2Laryngeal Masks 2Indocyanine Green 2Diagnostic Imaging 2tislelizumab 1Tomography 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Radiofrequency Ablation 1Positron-Emission Tomography 1Oxycodone 1Nitrous Oxide 1Neuromuscular Blockade 1Methylene Blue 1Magnetic Resonance Imaging 1Limonene 1Fluoroscopy 1Fluorodeoxyglucose F18 1Drug Delivery Systems 1Carbon Dioxide 1Blood Specimen Collection 1Aspirin 1Anti-Bacterial Agents 1Anterior Temporal Lobectomy 1Anesthetics, Local 1Anesthesia, General 1Anesthesia 14-(3-fluoropropyl)glutamic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Pulmonary Nodules × tislelizumab × Clear all
NCT04047186 2025-09-23

Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules

Tongji Hospital

Phase 2 Completed
12 enrolled
Thoracic

Lung Neoplasms, Multiple Pulmonary Nodules

Data powered by HemOnc (CC BY 4.0) Colophon âš¡